Aldeyra Therapeutics, Inc. (ALDX)

0.6497 0.00 (0.00%) USD  |  NASDAQ  |  Oct 23, 16:00
0.6486 0.00 (0.00%) Pre-Market: 20:00
More

Aldeyra Therapeutics Total Expenses (% of Quarterly Revenues)

Total Expenses (% of Quarterly Revenues) Chart

View Total Expenses (% of Quarterly Revenues) for ALDX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Total Expenses (% of Quarterly Revenues) Data

View and export this data back to . Start Trial.
Date Value

Total Expenses (% of Quarterly Revenues) Range, Past 5 Years

View Total Expenses (% of Quarterly Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Quarterly Revenues) Benchmarks

View Total Expenses (% of Quarterly Revenues) Benchmarks
Start Trial
Prime Medicine, Inc. Upgrade
Arrowhead Pharmaceuticals, Inc. Upgrade
Oncolytics Biotech, Inc. --
Sangamo Therapeutics, Inc. Upgrade
Sarepta Therapeutics, Inc. Upgrade